3651 results for «217»
3651 results
Tricuspid valve-in-valve case from London Bridge Hospital - London, United Kingdom - Session with LIVE case
24 Nov 2020 – From PCR Valves e-Course 2020
A 67-year-old male with degenerating 29mm Perimount tricuspid valve, right heart failure, and dyspnea on exertion (NYHA II), on optimal medical therapy…
View this virtual LIVE case transcatheter intervention recorded in London Bridge Hospital, London, United Kingdom – followed by LIVE call-ins from different city pods around...
Minimally invasive tricuspid valve repair and MAZE case from Leipzig Heart Center - Leipzig, Germany
24 Nov 2020 – From PCR Valves e-Course 2020
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
A 67-year-old low-risk active lady with severe tricuspid regurgitation, persistent atrial fibrillation with dilated atria and moderate RV dilatation but preserved RVEF.
This session...
PCR Valves e-Course 2020 closing ceremony
24 Nov 2020 – From PCR Valves e-Course 2020
On behalf of the Core Team, Bernard Prendergast thanks those who participated and contributed to PCR Valves e-Course 2020. During three days, imaging specialists, interventionists, cardiac surgeons and Heart Valve Teams from all across the world shared their knowledge, experience and practice, contributing to reinventing education and...
Minimally invasive mitral valve repair case - Session with LIVE case
23 Nov 2020 – From PCR Valves e-Course
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves e-Course 2020.
TAVI in bicuspid case from London Bridge Hospital, London, United Kingdom - Session with LIVE case
22 Nov 2020 – From PCR Valves e-Course 2020
A 77-year-old low-risk female patient with symptomatic aortic stenosis and bicuspid valve, suitable for TF access...
View this virtual LIVE case transcatheter intervention recorded in London Bridge Hospital, London, United Kingdom – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during...
PCR Valves e-Course 2020: Opening Ceremony
22 Nov 2020 – From PCR Valves e-Course 2020
Get a feel of the positive vibrations at #PCRvalves by watching a recording of the Opening ceremony, which was broadcast live from 3 TV studios in London, Paris and Toulouse! It shares how the comprehensive and innovative 3-day e-Course on the 3 valves – aortic, mitral...
Minimally invasive aortic valve and ascending aortic replacement case from Leipzig Heart Center - Leipzig, Germany - Session with LIVE case
22 Nov 2020 – From PCR Valves e-Course 2020
A 62-year-old active male with severe stenosis of bicuspid aortic valve, ascending aortic aneurysm and obesity…
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves...
MitraClip for primary mitral regurgitation case from Clinique Pasteur - Toulouse, France - Session with LIVE case
23 Nov 2020 – From PCR Valves e-Course 2020
View this virtual LIVE case transcatheter intervention recorded in Clinique Pasteur - Toulouse, France – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves e-Course 2020.
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578

Author
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024